P. Golumbek

发表

Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design.

E. Jaffee, D. Pardoll, K. Leong, 1993, Cancer research.

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

D. Pardoll, H. Karasuyama, A. Lazenby, 1991, Science.

Weekly oral prednisolone improves survival and strength in male mdx mice

A. Connolly, P. Golumbek, R. Keeling, 2007, Muscle & nerve.

RAG2 gene knockout in mice causes fatigue

A. Connolly, P. Golumbek, R. Keeling, 2007, Muscle & nerve.

Bone marrow-derived cells present MHC class I-restricted tumour antigens in priming of antitumour immune responses.

E. Jaffee, D. Pardoll, M. Ahmadzadeh, 1994, Ciba Foundation symposium.

Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccines.

E. Jaffee, D. Pardoll, H. Levitsky, 1992, Journal of immunotherapy : official journal of the Society for Biological Therapy.

One year outcome of boys with Duchenne muscular dystrophy using the Bayley-III scales of infant and toddler development.

J. Miller, J. Mendell, K. Bushby, 2014, Pediatric neurology.

De novo KCNA1 variants in the PVP motif cause infantile epileptic encephalopathy and cognitive impairment similar to recurrent KCNA2 variants

C. Wallgren‐Pettersson, R. Guerrini, C. Gurnett, 2018, American journal of medical genetics. Part A.

Strength and corticosteroid responsiveness of mdx mice is unchanged by RAG2 gene knockout

A. Connolly, P. Golumbek, R. Keeling, 2007, Neuromuscular Disorders.

Pharmacologic agents for pediatric neuroimmune disorders.

P. Golumbek, 2010, Seminars in pediatric neurology.

Regional CNS responses to IFN- (cid:2) determine lesion localization patterns during EAE pathogenesis

J. Russell, J. Lees, D. Dorsey, 2008 .

The antitumor immune response as a problem of self-nonself discrimination: Implications for immunotherapy

D. Pardoll, H. Levitsky, P. Golumbek, 1993, Immunologic research.

Clinical trial readiness in non‐ambulatory boys and men with duchenne muscular dystrophy: MDA–DMD network follow‐up

J. Miller, J. Mendell, A. Nicorici, 2016, Muscle & nerve.

Outcome reliability in non‐Ambulatory Boys/Men with duchenne muscular dystrophy

J. Miller, J. Mendell, A. Nicorici, 2015, Muscle & nerve.

The fate of CD4-8- T cell receptor-alpha beta+ thymocytes.

D. Pardoll, H. Levitsky, P. Golumbek, 1991, Journal of immunology.

Twice‐weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophy

R. Finkel, J. Mendell, A. Nicorici, 2019, Muscle & nerve.

A CCAAT DNA binding factor consisting of two different components that are both required for DNA binding.

E. Van Schaftingen, P. Golumbek, A. Hatamochi, 1988, The Journal of biological chemistry.

Point mutations and small substitution mutations in three different upstream elements inhibit the activity of the mouse alpha 2(I) collagen promoter.

G. Karsenty, P. Golumbek, B. De Crombrugghe, 1988, The Journal of biological chemistry.

Effects of flunarizine on spontaneous synaptic currents in rat neocortex

J. Rho, W. Spain, P. Golumbek, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

E. Jaffee, G. Dranoff, D. Pardoll, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.

E. Jaffee, D. Pardoll, M. Ahmadzadeh, 1994, Science.

Selective activation of transcription by a novel CCAAT binding factor.

G. Karsenty, S. Maity, P. Golumbek, 1988, Science.

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

B. Vogelstein, E. Fearon, J. Simons, 1990, Cell.

Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network

J. Miller, J. Mendell, A. Nicorici, 2013, Neuromuscular Disorders.

Child Neurology: Brown-Vialetto-Van Laere syndrome

M. Shinawi, S. Culican, Robi N Maamari, 2018, Neurology.

Dramatic visual recovery after delayed riboflavin therapy

M. Shinawi, S. Culican, Robi N Maamari, 2022 .

Molecular engineering of the antitumor immune response.

D. Pardoll, H. Levitsky, P. Golumbek, 1992, Bone marrow transplantation.

Regional CNS responses to IFN-γ determine lesion localization patterns during EAE pathogenesis

J. Russell, John H. Russell, J. Lees, 2008, The Journal of experimental medicine.

Brain-Derived Neurotrophic Factor and Autoantibodies to Neural Antigens in Sera of Children with Autistic Spectrum Disorders, Landau-Kleffner Syndrome, and Epilepsy

R. Neuman, J. Riviello, A. Connolly, 2006, Biological Psychiatry.

Neurologic manifestations of celiac disease

A. Cross, P. Golumbek, 2003, Neurology.

Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function

A. Connolly, C. Weihl, G. Hu, 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Autism: A Neurological Disorder of Early Brain Development

P. Golumbek, 2007 .

Nusinersen versus Sham Control in Infantile‐Onset Spinal Muscular Atrophy

R. J. Ramamurthi, S. Y. Kim, H. Y. Wang, 2017, The New England journal of medicine.